Cargando…
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden
BACKGROUND: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessing the impact of their potential viral properties on the probability of future transmission dominance and public health burden is fundamental in guiding ongoing COVID-19 control strategies. METHODS: W...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311342/ https://www.ncbi.nlm.nih.gov/pubmed/35899148 http://dx.doi.org/10.1038/s43856-022-00154-z |
_version_ | 1784753579027857408 |
---|---|
author | Le Rutte, Epke A. Shattock, Andrew J. Chitnis, Nakul Kelly, Sherrie L. Penny, Melissa A. |
author_facet | Le Rutte, Epke A. Shattock, Andrew J. Chitnis, Nakul Kelly, Sherrie L. Penny, Melissa A. |
author_sort | Le Rutte, Epke A. |
collection | PubMed |
description | BACKGROUND: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessing the impact of their potential viral properties on the probability of future transmission dominance and public health burden is fundamental in guiding ongoing COVID-19 control strategies. METHODS: With an individual-based transmission model, OpenCOVID, we simulated three viral properties; infectivity, severity, and immune-evading ability, all relative to the Delta variant, to identify thresholds for Omicron’s or any emerging VOC’s potential future dominance, impact on public health, and risk to health systems. We further identify for which combinations of viral properties current interventions would be sufficient to control transmission. RESULTS: We show that, with first-generation SARS-CoV-2 vaccines and limited physical distancing in place, a VOC’s potential future dominance is primarily driven by its infectivity, which does not always lead to an increased public health burden. However, we also show that highly immune-evading variants that become dominant, even in the case of reduced variant severity, would likely require alternative measures to avoid strain on health systems, such as strengthened physical distancing measures, novel treatments, and second-generation vaccines. Expanded vaccination, that includes a booster dose for adults and child vaccination strategies, is projected to have the biggest public health benefit for a highly infective, highly severe VOC with low immune-evading capacity. CONCLUSIONS: These findings provide quantitative guidance to decision-makers at a critical time while Omicron’s properties are being assessed and preparedness for emerging VOCs is eminent. We emphasise the importance of both genomic and population epidemiological surveillance. |
format | Online Article Text |
id | pubmed-9311342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93113422022-07-26 Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden Le Rutte, Epke A. Shattock, Andrew J. Chitnis, Nakul Kelly, Sherrie L. Penny, Melissa A. Commun Med (Lond) Article BACKGROUND: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessing the impact of their potential viral properties on the probability of future transmission dominance and public health burden is fundamental in guiding ongoing COVID-19 control strategies. METHODS: With an individual-based transmission model, OpenCOVID, we simulated three viral properties; infectivity, severity, and immune-evading ability, all relative to the Delta variant, to identify thresholds for Omicron’s or any emerging VOC’s potential future dominance, impact on public health, and risk to health systems. We further identify for which combinations of viral properties current interventions would be sufficient to control transmission. RESULTS: We show that, with first-generation SARS-CoV-2 vaccines and limited physical distancing in place, a VOC’s potential future dominance is primarily driven by its infectivity, which does not always lead to an increased public health burden. However, we also show that highly immune-evading variants that become dominant, even in the case of reduced variant severity, would likely require alternative measures to avoid strain on health systems, such as strengthened physical distancing measures, novel treatments, and second-generation vaccines. Expanded vaccination, that includes a booster dose for adults and child vaccination strategies, is projected to have the biggest public health benefit for a highly infective, highly severe VOC with low immune-evading capacity. CONCLUSIONS: These findings provide quantitative guidance to decision-makers at a critical time while Omicron’s properties are being assessed and preparedness for emerging VOCs is eminent. We emphasise the importance of both genomic and population epidemiological surveillance. Nature Publishing Group UK 2022-07-25 /pmc/articles/PMC9311342/ /pubmed/35899148 http://dx.doi.org/10.1038/s43856-022-00154-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Le Rutte, Epke A. Shattock, Andrew J. Chitnis, Nakul Kelly, Sherrie L. Penny, Melissa A. Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title | Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title_full | Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title_fullStr | Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title_full_unstemmed | Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title_short | Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden |
title_sort | modelling the impact of omicron and emerging variants on sars-cov-2 transmission and public health burden |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311342/ https://www.ncbi.nlm.nih.gov/pubmed/35899148 http://dx.doi.org/10.1038/s43856-022-00154-z |
work_keys_str_mv | AT lerutteepkea modellingtheimpactofomicronandemergingvariantsonsarscov2transmissionandpublichealthburden AT shattockandrewj modellingtheimpactofomicronandemergingvariantsonsarscov2transmissionandpublichealthburden AT chitnisnakul modellingtheimpactofomicronandemergingvariantsonsarscov2transmissionandpublichealthburden AT kellysherriel modellingtheimpactofomicronandemergingvariantsonsarscov2transmissionandpublichealthburden AT pennymelissaa modellingtheimpactofomicronandemergingvariantsonsarscov2transmissionandpublichealthburden |